Alison K. Esser

457 total citations
11 papers, 182 citations indexed

About

Alison K. Esser is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Alison K. Esser has authored 11 papers receiving a total of 182 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Immunology. Recurrent topics in Alison K. Esser's work include Protease and Inhibitor Mechanisms (3 papers), Nanoparticle-Based Drug Delivery (1 paper) and Retinal Imaging and Analysis (1 paper). Alison K. Esser is often cited by papers focused on Protease and Inhibitor Mechanisms (3 papers), Nanoparticle-Based Drug Delivery (1 paper) and Retinal Imaging and Analysis (1 paper). Alison K. Esser collaborates with scholars based in United States, Russia and Germany. Alison K. Esser's co-authors include Michael D. Henry, Katherine N. Weilbaecher, Michael B. Cohen, Jingyu Xiang, Xinming Su, Francesca Fontana, Michael H. Ross, Michael R. Miller, Charles F. Lynch and Kevin P. Campbell and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Cancer Research.

In The Last Decade

Alison K. Esser

10 papers receiving 180 citations

Peers

Countries citing papers authored by Alison K. Esser

Since Specialization

Citations

This map shows the geographic impact of Alison K. Esser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison K. Esser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison K. Esser more than expected).

Fields of papers citing papers by Alison K. Esser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison K. Esser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison K. Esser. The network helps show where Alison K. Esser may publish in the future.

Co-authorship network of co-authors of Alison K. Esser

This figure shows the co-authorship network connecting the top 25 collaborators of Alison K. Esser. A scholar is included among the top collaborators of Alison K. Esser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison K. Esser. Alison K. Esser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Transferrin receptor in primary and metastatic breast cancer: Evaluation of expression and experimental modulation to improve molecular targeting 2023 ·PLoS ONE ·Francesca Fontana, Alison K. Esser, Christopher Egbulefu, Partha Karmakar, Xinming Su, John S. Allen, Yalin Xu, Jennifer L. Davis, (unknown), Jingyu Xiang, Kristin A. Kwakwa, Brad Manion, Suzanne J. Bakewell, Shunqiang Li, Haeseong Park, Gregory M. Lanza, Samuel Achilefu, Katherine N. Weilbaecher	10
2	Nanotherapy delivery of c-myc inhibitor targets Protumor Macrophages and preserves Antitumor Macrophages in Breast Cancer 2020 ·Theranostics ·Alison K. Esser, Michael H. Ross, Francesca Fontana, Xinming Su, (unknown), (unknown), Yalin Xu, Jingyu Xiang, Anne H. Schmieder, Xiaoxia Yang, Grace Cui, Michael J. Scott, Samuel Achilefu, Jay Chauhan, Steven Fletcher, Gregory M. Lanza, Katherine N. Weilbaecher	31
3	HTLV-1 viral oncogene HBZ induces osteolytic bone disease in transgenic mice 2017 ·Oncotarget ·Alison K. Esser, Daniel A. Rauch, Jingyu Xiang, John C. S. Harding, (unknown), Michael H. Ross, Xinming Su, (unknown), Devra Huey, Yalin Xu, Kiran Vij, Patrick L. Green, Thomas J. Rosol, Stefan Niewiesk, Lee Ratner, Katherine N. Weilbaecher	12
4	CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer 2015 ·Molecular Cancer Therapeutics ·Jingyu Xiang, Michelle A. Hurchla, Francesca Fontana, Xinming Su, Sarah R. Amend, Alison K. Esser, Garry J. Douglas, (unknown), Kathryn E. Luker, Timothy Pluard, Foluso O. Ademuyiwa, Bárbara Romagnoli, Gérald Tuffin, Éric Chevalier, Gary D. Luker, Michael Bauer, Johann Zimmermann, Rebecca Aft, Klaus Dembowsky, Katherine N. Weilbaecher	49
5	Dual-therapy with αvβ3-targeted Sn2 lipase-labile fumagillin-prodrug nanoparticles and zoledronic acid in the Vx2 rabbit tumor model 2015 ·Nanomedicine Nanotechnology Biology and Medicine ·Alison K. Esser, Anne H. Schmieder, Michael H. Ross, Jingyu Xiang, Xinming Su, Grace Cui, Huiying Zhang, Xiaoxia Yang, John S. Allen, Todd A. Williams, Samuel A. Wickline, Dipanjan Pan, Gregory M. Lanza, Katherine N. Weilbaecher	13
6	Loss of LARGE2 Disrupts Functional Glycosylation of α-Dystroglycan in Prostate Cancer 2012 ·Journal of Biological Chemistry ·Alison K. Esser, Michael R. Miller, Qin Huang, (unknown), Daniel Beltrán-Valero de Bernabé, Christopher S. Stipp, Kevin P. Campbell, Charles F. Lynch, Bruce A. Smith, Michael B. Cohen, Michael D. Henry	33
7	Abstract 439: Glycosylation of α-dystroglycan in prostate cancer: Prognostic implications and regulation by LARGE2 2012 ·Cancer Research ·Michael R. Miller, Alison K. Esser, Christine J. Weydert, (unknown), Bruce A. Smith, Robert L. Vessella, Charles F. Lynch, Michael B. Cohen, Michael D. Henry	0
8	Dystroglycan is not required for maintenance of the luminal epithelial basement membrane or cell polarity in the mouse prostate 2010 ·The Prostate ·Alison K. Esser, Michael B. Cohen, Michael D. Henry	11
9	Endothelin-1 inhibits prostate cancer growth in vivo through vasoconstriction of tumor-feeding arterioles 2009 ·Cancer Biology & Therapy ·Christine J. Weydert, Alison K. Esser, (unknown), Justin M. Drake, J. Matthew Barnes, Michael D. Henry	16
10	Increased Prevalence of Apolipoprotein E2 in Patients with Retinitis Pigmentosa 1987 ·Ophthalmic Research ·C. Jahn, K. Oette, Alison K. Esser, Klaus von Bergmann, O. Leiß	6
11	[New light on the origin of cataract operation]. 1956 ·PubMed ·Alison K. Esser	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact